Rocket One Inc. (RKTO) stock
RKTONasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.30−0.01 (-4.64%)
Close on Nov 18, 2026Market cap $7.53MP/E –Yield –
Rocket One r&d expenses
Research and development expenses are spending on new products and technology.
Rocket One's R&D Expenses for the twelve months ending Jun 30, 2026 was $6.42M, up 27.6% year over year. For fiscal 2025 it was $5.95M, up 83.0% from the year before. The highest annual figure on record is $7.35M in fiscal 2021.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.95M | +83.0% |
| FY2024 | Dec 31, 2024 | $3.25M | -13.1% |
| FY2023 | Dec 31, 2023 | $3.74M | -24.1% |
| FY2022 | Dec 31, 2022 | $4.93M | -33.0% |
| FY2021 | Dec 31, 2021 | $7.35M | +222.4% |
| FY2020 | Dec 31, 2020 | $2.28M | +12.7% |
| FY2019 | Dec 31, 2019 | $2.03M | +157.9% |
| FY2018 | Dec 31, 2018 | $785.27K | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $1.96M | +88.1% |
| Q1 FY2026 | Mar 31, 2026 | $1.52M | -22.4% |
| Q4 FY2025 | Dec 31, 2025 | $1.31M | +26.5% |
| Q3 FY2025 | Sep 30, 2025 | $1.63M | +64.3% |
| Q2 FY2025 | Jun 30, 2025 | $1.04M | +30.5% |
| Q1 FY2025 | Mar 31, 2025 | $1.96M | +46.5% |
| Q4 FY2024 | Dec 31, 2024 | $1.04M | +56.5% |
| Q3 FY2024 | Sep 30, 2024 | $994.47K | +5.5% |
| Q4 FY2023 | Dec 31, 2023 | $796.76K | -48.9% |
| Q3 FY2023 | Sep 30, 2023 | $1.34M | -7.9% |
| Q2 FY2023 | Jun 30, 2023 | $664.00K | -31.6% |
| Q1 FY2023 | Mar 31, 2023 | $942.89K | -0.6% |
| Q4 FY2022 | Dec 31, 2022 | $1.56M | -19.8% |
| Q3 FY2022 | Sep 30, 2022 | $1.45M | -31.7% |
| Q2 FY2022 | Jun 30, 2022 | $971.18K | -44.6% |
| Q1 FY2022 | Mar 31, 2022 | $948.38K | -38.1% |
| Q4 FY2021 | Dec 31, 2021 | $1.95M | +932.1% |
| Q3 FY2021 | Sep 30, 2021 | $2.12M | +310.1% |
| Q2 FY2021 | Jun 30, 2021 | $1.75M | +88.8% |
| Q1 FY2021 | Mar 31, 2021 | $1.53M | +136.9% |
| Q4 FY2020 | Dec 31, 2020 | $188.60K | -81.3% |
| Q3 FY2020 | Sep 30, 2020 | $517.84K | +5.6% |
| Q2 FY2020 | Jun 30, 2020 | $927.70K | +138.5% |
| Q1 FY2020 | Mar 31, 2020 | $647.23K | +380.3% |
| Q4 FY2019 | Dec 31, 2019 | $1.01M | +343.7% |
| Q3 FY2019 | Sep 30, 2019 | $490.27K | +63.7% |
| Q2 FY2019 | Jun 30, 2019 | $388.93K | +79.5% |
| Q1 FY2019 | Mar 31, 2019 | $134.75K | +226.7% |
| Q4 FY2018 | Dec 31, 2018 | $227.88K | – |
| Q3 FY2018 | Sep 30, 2018 | $299.49K | – |
| Q2 FY2018 | Jun 30, 2018 | $216.67K | – |
| Q1 FY2018 | Mar 31, 2018 | $41.24K | – |
See a number that looks wrong?